Navigation Links
Blood Flow Measurement Boosts Stent Outcomes
Date:1/14/2009

l stenoses [blockages], you can use stents only on those that are dangerous for the patient."

The FFR technology is not currently available in many medical centers, however. Its initial cost is $20,000, with a charge of about $600 for each use. "But its use will definitely increase if you look at these results, which I call impressive," Pijls said.

FFR is measured by inserting a pressure sensor mounted on a guidewire to the site of blockages in the arteries. FFR equipment is marketed by St. Jude Medical.

"This will provide impetus for some catheter laboratories to buy it, but we don't use it on a routine basis," said Dr. Stephen G. Ellis, director of the cardiac catheterization laboratory at the Cleveland Clinic and author of an editorial accompanying the report.

FFR measurements were used to guide stent implants in about 10 percent of cases at the Cleveland Clinic in the past year, Ellis said. "I doubt if we will be using it in more than 25 percent of cases," he said.

Cost is an issue, he said, since "economic times are hard for hospitals now. We don't have enough data on costs. What we need is a U.S.-based study of the cost involved. One would assume that because it reduces the number of second procedures, that would offset the roughly $600 cost per case."

The group that did the study "is now doing a more extended cost-benefit analysis," Pijls said.

The new report probably will not lead to a surge in American use of the FFR technology, according to Ellis, but its use is bound to widen. "This is not a revolution but a devolution," he said. "It is logical to treat only blockages that are physiologically significant."

More information

There's much more on stents at the U.S. Food and Drug Administration.



SOURCES: Nico H. J. Pijls, M.D
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Blood Emergency: Blood Supply Tips Into Danger Zone
2. University of Ottawa Heart Institute Scientists Successfully Develop Novel Biomaterial to Help Grow New Blood Vessels
3. Doctors Re-Examine Blood Thinners to Prevent Strokes
4. Seventeen Months After Cord Blood Transplant - Child is Free of Signs of Cancer
5. Penn researchers unlock molecular origin of blood stem cells
6. OHSU School of Dentistry team discovers new molecule in blood-pressure control system
7. Donate Blood Today -- Save Up to Three Lives
8. Viagra May Shield Heart From Blood Pressure Damage
9. Blood Drive Held in Honor of Gloucester City Resident - Evan Goldglantz
10. Young blood fights cancer
11. Rising Blood Sugar May Harm the Aging Brain

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Blood Flow Measurement Boosts Stent Outcomes
Blood Flow Measurement Boosts Stent Outcomes
(Date:11/9/2009)...lanted with new cells regained sexual function, st...ay News) -- Researchers were able to restore sexua...ing new penile tissue in the lab and implanting it...tion is a ways off, researchers say the technique ...function in men. , "We were able to show the ti...
(Date:11/9/2009)... Fast food chains are often blamed f...cent poll by Fitness.com.au however finds that 80%...responsibility. , (PRWEB)...ns, and video games were behind Australia’s ...re than just innocent bystanders. A recent survey ...
(Date:11/9/2009)... New study highlights positive influ... Rosemont, IL (Vocus) November...one health decreases. Recent research has highligh...ents to help prevent these issues. However, a new ... Sports Health: A Multidisciplinary Approach reve...
(Date:11/9/2009)...ON, Tenn., Nov. 9 Health Connect P...d it will host their inaugural Hospital O.R. and S... the Marriott Renaissance Hotel in Nashville, Tenn...than 100 hospital operating room directors and man...h systems in the country. Some of the confirmed pr...
(Date:11/9/2009)...IT, Nov. 9 For the thir...r Center has been selected the most preferred hosp...ing to a survey by the National Research Corporati.../prnh/20071106/KARMANOSLOGO ) ,, The annual su...between September 2008 and August 2009. Survey res...
Breaking Medicine News(10 mins):Health News:Scientists Grow New Penile Tissue in the Lab 2Health News:Scientists Grow New Penile Tissue in the Lab 3Health News:Fitness.com.au Poll Finds 80% Blame Parents For Our Overweight Kids 2Health News:High Impact Sports Participation May Improve Bone Mineral Density in Mature Athletes 2Health News:Health Connect Partners Hosts Hospital O.R. & Surgery Center Conference 2Health News:Karmanos Cancer Center Most Preferred Hospital for Cancer Care in Southeast Michigan, Third Consecutive Year 2
...Chat, Blogs, Events & More Benefit Online Nurse Co...ly designed for,business professionals to connect ...the Internet. Now there,s a Web site rising to the...rseconnect.com ) is a user-friendly site for colla...
...IDGE, Mass., Dec. 21 Millennium,Pharmaceuticals, ...on of a,supplemental new drug application (sNDA) w...r VELCADE in the treatment of patients with,previo...domized clinical trials for patients in this treat...
...SVILLE, Pa., Dec. 21 RESPIRONICS, INC.,(Nasdaq: ...itive merger,agreement pursuant to which Royal Phi...ill commence a tender offer to acquire all of the ...nts a,premium of approximately 31% over Respironic...
...O, Ohio, Dec. 20 Upon an ex parte motion,by the S...chigan (SEIU), a,temporary restraining order (TRO)...hirtieth Judicial Circuit Court in Ingham County, ...ed to,completing the pending transaction between M...
...NGTON, Dec. 20 The Campaign to End,Obesity (the C...mocratic,and Republican presidential candidates fa...ifically plans to address the Nation,s obesity epi...e,candidates, campaign offices in early November.,...
...NGTON, Dec. 20 Today URAC called for,comments on ... Health Web,Site, HIPAA Privacy (Business Associat... Associate and Covered Entity) accreditation progr...dline for public comment is Feb. 10, 2008., (LOGO...
Other Medicine News:Health News:Professional Networking Web Site, NurseConnect.com Launches Innovative Features 2Health News:Millennium Submits sNDA for VELCADE(R) (Bortezomib) for Injection for the Treatment of Front-Line Multiple Myeloma 2Health News:Millennium Submits sNDA for VELCADE(R) (Bortezomib) for Injection for the Treatment of Front-Line Multiple Myeloma 3Health News:Millennium Submits sNDA for VELCADE(R) (Bortezomib) for Injection for the Treatment of Front-Line Multiple Myeloma 4Health News:Millennium Submits sNDA for VELCADE(R) (Bortezomib) for Injection for the Treatment of Front-Line Multiple Myeloma 5Health News:Royal Philips Electronics to Acquire Respironics for USD $66.00 Per Share 2Health News:Royal Philips Electronics to Acquire Respironics for USD $66.00 Per Share 3Health News:Royal Philips Electronics to Acquire Respironics for USD $66.00 Per Share 4Health News:Royal Philips Electronics to Acquire Respironics for USD $66.00 Per Share 5Health News:Manor Care To Vigorously Contest TRO 2Health News:2008 Presidential Hopefuls Fail to Respond to Questions About Obesity in U.S. 2Health News:URAC Calls for Comments on Changes to Standards for Health Web Site, HIPAA Privacy and Security Accreditation Programs 2
(Date:11/9/2009)...if., Nov. 9 Clarient, In...ices resource for pathologists, oncologists and th... is scheduled to make presentations at two upcomin... first presentation will be made at the Lazard Cap... 1:40 pm EST on Tuesday, November 17. The conferen...
(Date:11/7/2009)...., Nov. 7 Patients reported C1-est...ve therapy in treating acute swelling attacks at a...ic disorder, according to data presented today at ... Immunology (ACAAI) Annual Meeting. The results co...ed in parallel with the ongoing, prospective, open...
(Date:11/6/2009)...v. 6 Oxygen Biotherapeut...ed that a previously approved reverse split of its...ding on Monday, Nov. 9, 2009 on a 1-for-15 split-a... will trade under the new symbol OXBT. The stock a...n the split becomes effective. ,, "This reverse...
Breaking Medicine Technology:Clarient to Present at Upcoming Healthcare Investor Conferences in New York City 2Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care 2Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care 3Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 2Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 3Dr Ken Dychtwald to Discuss Looming Caregiver Crunch and the Importance of Proactive Long Term Care Planning 60239 1Dr Ken Dychtwald to Discuss Looming Caregiver Crunch and the Importance of Proactive Long Term Care Planning 60239 2Health Partners to Offer Health Insurance Through the Childrens Health Insurance Program 60234 1Health Partners to Offer Health Insurance Through the Childrens Health Insurance Program 60234 2Is Poor Medical Equipment Planning Costing your Healthcare Project Wasted Dollars and Delays 3F ECRI Institute outlines best practices to ensure bette 5783 1Is Poor Medical Equipment Planning Costing your Healthcare Project Wasted Dollars and Delays 3F ECRI Institute outlines best practices to ensure bette 5783 2Is Poor Medical Equipment Planning Costing your Healthcare Project Wasted Dollars and Delays 3F ECRI Institute outlines best practices to ensure bette 5783 3
...gen Spine, a leading,developer of innovative spina...ive disc disease, announced today that it has rece...mbar Artificial Disc in the European,Union., "We ... Prosthesis has,received CE mark approval," said A... Spine. "This represents an important milestone in...
...olerx, Inc., a,biopharmaceutical company engaged i... for the treatment of immune-mediated diseases, an...moved a modified version of TRX1,MTRX1011A, an ant... trial,that has begun enrolling patients. The clin...ty of both single and multiple doses of MTRX1011A....
Other Medicine Technology:Nexgen Spine Receives CE Mark Approval for the Physio-L(R) Artificial Disc 2Tolerx Announces Achievement of Milestones upon anti-CD4 Antibody Program Advancement and Initiation of Phase 1 Clinical Trial 2Tolerx Announces Achievement of Milestones upon anti-CD4 Antibody Program Advancement and Initiation of Phase 1 Clinical Trial 3
Quality Module QS I
High Throughput Sorter RSD ProVolume
...ection Reagents provide molecular labs a more adva...y using our MGB technology, combined with post-PCR...able to provide molecular labs more powerful tools...organisms or genetic mutations associated with dis...
...Rs* are specifically designed for PCR amplificatio...orescence detection systems. The NGEN product line...associated with cystic fibrosis, thrombosis, and h... the detection of sequences associated with severa...
Medicine Products: